Angiotensin News and Research

RSS
Angiotensin is an oligopeptide in the blood that causes vasoconstriction, increased blood pressure, and release of aldosterone from the adrenal cortex. It is a powerful dipsogen. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It plays an important role in the renin-angiotensin system.
Humans versus viruses - Can we avoid extinction in near future?

Humans versus viruses - Can we avoid extinction in near future?

Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines

Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines

SARS-CoV-2 can alter bone marrow macrophage (BMM)-to-osteoclast differentiation, study finds

SARS-CoV-2 can alter bone marrow macrophage (BMM)-to-osteoclast differentiation, study finds

Curcumin nanosystems could be powerful COVID-19 therapeutics

Curcumin nanosystems could be powerful COVID-19 therapeutics

Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein

Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein

Modeling study suggests how different SARS-CoV-2 mutations prevent antibody binding

Modeling study suggests how different SARS-CoV-2 mutations prevent antibody binding

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Can biomaterials offer novel therapeutic strategies against COVID-19?

Can biomaterials offer novel therapeutic strategies against COVID-19?

Updated Moderna vaccines neutralize South African SARS-CoV-2 variant in mice

Updated Moderna vaccines neutralize South African SARS-CoV-2 variant in mice

Study sheds light on reduced neutralization of SARS-CoV-2 variants of concern

Study sheds light on reduced neutralization of SARS-CoV-2 variants of concern

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

Experimental evidence that ADAM17 inhibition prevents severe COVID-19

Experimental evidence that ADAM17 inhibition prevents severe COVID-19

Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion

Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion

A host of mutations could compromise COVID-19 vaccines and antibody therapies

A host of mutations could compromise COVID-19 vaccines and antibody therapies

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

ACE2 homology in laboratory and wild animals

ACE2 homology in laboratory and wild animals

Could Zebrafish larvae be a novel animal model for SARS-CoV-2?

Could Zebrafish larvae be a novel animal model for SARS-CoV-2?

Early cardiac events pose major and different risks in close relatives, finds study

Early cardiac events pose major and different risks in close relatives, finds study